Search results
Results from the WOW.Com Content Network
The nomenclature of monoclonal antibodies is a naming scheme for assigning generic, or nonproprietary, names to monoclonal antibodies. An antibody is a protein that is produced in B cells and used by the immune system of humans and other vertebrate animals to identify a specific foreign object like a bacterium or a virus .
The remaining syllables of the INNs, as well as the column Source, are explained in Nomenclature of monoclonal antibodies. Types of monoclonal antibodies with other structures than naturally occurring antibodies. The abbreviations in the column Type are as follows: mab: whole monoclonal antibody; Fab: fragment, antigen-binding (one arm)
Comparison of monoclonal antibodies (brown: human, blue: non-human): top row: mouse, chimeric; bottom row: humanized, chimeric/humanized, human; The substems according to the nomenclature of monoclonal antibodies are shown below each antibody. Date: 14 February 2010, 13:34 (UTC) Source: Antibody_je2.neutral.svg; General policies for monoclonal ...
He is a true translational investigator, since he used these monoclonal antibodies to classify human B-cell leukemia and lymphomas as well as to create therapeutic agents for patients. . . More importantly, he was the first in the world to administer a monoclonal antibody to a human (a patient with B-cell lymphoma)." [11]
CD20 antibody bound with the radioactive isotope, 90Y, induces radiation-dependent cell lysis. Non-Hodgkin's lymphoma and follicular lymphoma. Thrombocytopenia, neutropenia, anaemia, hypotension and secondary malignancies. Ipilimumab: IV: CTLA4 antibody that causes immune system-mediated lysis of the tagged cell: Unresectable or metastatic ...
It is about the nomenclature of *therapeutic* monoclonal antibodies. A monoclonal antibody can be called anything you like. It is only when a monoclonal antibody which is intended to become a drug reaches the stage of development where an INN is required that the system so tortuously described in the article kicks in.
The CD nomenclature was proposed and established in the 1st International Workshop and Conference on Human Leukocyte Differentiation Antigens (HLDA), held in Paris in 1982. [4] [5] This system was intended for the classification of the many monoclonal antibodies (mAbs) generated by different laboratories around the world against epitopes on the surface molecules of leukocytes (white blood cells).
To change this template's initial visibility, the |state= parameter may be used: {{Monoclonals for immune system | state = collapsed}} will show the template collapsed, i.e. hidden apart from its title bar. {{Monoclonals for immune system | state = expanded}} will show the template expanded, i.e. fully visible.